India Seeks PLI Expansion & API Support Ahead of Budget 2026

Indian pharma and MedTech stakeholders are urging the government to expand the Production-Linked Incentive (PLI) scheme to cover critical APIs and reduce import duties on advanced radiotherapy equipment — aimed at strengthening domestic manufacturing and improving access to cutting-edge technologies.

Source: Economic Times (The Economic Times)

`Healthcare Dealmakers See a Big M&A Year in 2026`

Healthcare dealmakers are heading to the J.P. Morgan Healthcare Conference with optimism for mega-mergers this year — potentially outpacing even 2019 and 2021 — driven by easing antitrust scrutiny and a rebound in healthcare valuation. Oncology, neuroscience, rare diseases and obesity treatments are expected to be major M&A battlegrounds.

Source: Reuters (Reuters)

`U.S. House Passes Health Subsidy Renewal`

The U.S. House has passed legislation to renew key health subsidies, securing continued support for millions of Americans dependent on marketplace insurance plans — a major win for healthcare affordability amid inflationary pressures.

Source: Reuters (Reuters)

`Global Healthcare Private Equity Hits Record $190B in 2025`

Private equity investment in healthcare reached a record $190 billion deal value in 2025, driven by several billion-dollar transactions that highlight growing investor confidence in health systems, digital health, biotech and medical devices globally.

Source: Morningstar/PR Newswire (Morningstar)

`New AI Healthcare Performance Standards Report Published`

Vi has released its 2026 State of AI Reports, setting new benchmarks for AI performance in healthcare, biopharma, and wellness ecosystems — indicating how enterprise AI is redefining diagnostics, operations, patient engagement and wellness metrics across providers.

Source: PR Newswire (PR Newswire)

`Healthcare Analytics Market Set for Massive Growth`

The global healthcare analytics market is forecast to generate $145.81 billion by 2032, growing at a CAGR of 24.1%, reflecting surging demand for data-driven decision-making, predictive care, operational efficiency and patient outcome improvements.

Source: Verified Market Research / Yahoo Finance (Yahoo Finance)

`Global Action on Antibiotic Resistance Moves Forward`

Experts are calling for a unified “One Health” responseto antibiotic resistance, emphasizing coordinated strategies across human, animal and environmental health sectors to curb the threat of superbugs and preserve antibiotic efficacy.

Source: European Sting (European Sting)

`Psilera Appoints Neuroscience Expert as CMO`

Psilera, a biopharmaceutical company focused on novel therapies, appointed neuroscience veteran Dr. Magali Haas, MD/PhDas its Chief Medical Officer — signaling a renewed focus on advancing clinical programs in neurodegenerative and CNS conditions.

Source: Newswise (Newswise)

`Consumer Health Giant Restructures Leadership`

Haleon — a leading consumer health company — announced a new Chief Growth Officer role and reorganised into six operating units to sharpen focus on innovation, product development, and global market expansion.

Source: Sharecast (Sharecast)

📌 What Today’s Headlines Reveal

M&A & capital flowsare returning strongly in healthcare, with big deals expected in 2026.
Policy support and subsidiesremain critical for access and sector stability.
Private equity confidencesignals deep investor interest.
AI & analyticscontinue to redefine care delivery and operations.
Clinical leadership changesand structural reorganisations show industry maturation.
Global health risks like antibiotic resistancerequire unified action.
Domestic manufacturing policy discussions position India for future growth.

✨ Follow Daily Pulse every day for curated, credible, and current healthcare & pharma insights from around the world. #DailyPulse #HealthcareNews #PharmaUpdates #HealthTech #AIinHealthcare #GlobalHealth #PolicyTrends #MergersAndAcquisitions

Disclaimer: The views and opinions expressed in this interview are those of the author and do not reflect the official position of any medical body or organization. 
The author is not a medical doctor; however, the insights shared are based on over a decade of working experience in the healthcare sector start-ups. 
Readers should consult with a qualified healthcare professional for medical advice or information related to their specific situation.

Please follow our page Aristocrat Media for more updates 
For Enquiries connect us on:
marketing@aristocrat-media.com